During the past decade, Marin Oncology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Marin Oncology Associates" are "Multiple Myeloma" (2 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Myelodysplastic Syndrome" (1 trials). Many other conditions were trialed in "Marin Oncology Associates" in a lesser frequency.

Most popular intervention types in "Marin Oncology Associates" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "Placebo" (2 trials), "Pomalidomide" (2 trials), "Best Supportiv Care (BSC)" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marin Oncology Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Marin Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Marin Oncology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marin Oncology Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".